Literature DB >> 6223767

Depletion of helper/inducer T cells after thymectomy in myasthenic patients.

S Berrih, H Le Brigand, P Levasseur, C Gaud, J F Bach.   

Abstract

Using monoclonal anti-T-cell antibodies, we have studied peripheral blood T-cell subsets in 53 patients with myasthenia gravis before and after thymectomy (Tx). Before Tx, the mean OKT4/OKT8 ratio was higher in patients than in controls. Furthermore patients showed a high number of cells reacting simultaneously with the OKT4 and OKT8 antibodies. Shortly after surgery, the helper/suppressor ratio was increased in most of the patients, and the doubly reactive subset decreased to normal levels. However, 6 to 12 months after Tx the OKT4/OKT8 ratio was significantly decreased, particularly in patients showing clinical improvement. The percentage of total T cells was slightly but significantly reduced. A group of 14 patients studied more than 2 years after Tx presented very low OKT4/OKT8 ratios. Thymectomy in MG appears to lead to a gradual decrease of the T-helper subset which could contribute to its favorable effect on the course of the disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6223767     DOI: 10.1016/0090-1229(83)90161-7

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  7 in total

1.  Antibodies to acetylcholine receptors in myasthenia gravis. In vitro synthesis by peripheral blood lymphocytes before and after thymectomy.

Authors:  J B Kuks; P C Limburg; H J Oosterhuis; T H The
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

2.  Surgical treatment of myasthenia gravis and evaluation of its efficacy.

Authors:  T C Pan; Q F Chen; L H Zhang; Y Z Shen; Z P Xie; M S Yang; B T Bu; X B Cao
Journal:  J Tongji Med Univ       Date:  1991

Review 3.  Immunopathogenesis and treatment of myasthenia gravis.

Authors:  A I Levinson; B Zweiman; R P Lisak
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

Review 4.  Phenotypic and functional analysis of lymphocytes in myasthenia gravis.

Authors:  A I Levinson; R P Lisak; B Zweiman; M Kornstein
Journal:  Springer Semin Immunopathol       Date:  1985

5.  Clinical measurement of antibodies against acetylcholine receptor (AchR), SOD and LPO in patients with myasthenia gravis (MG) before and after thymectomy.

Authors:  T C Pan; M S Yang; X B Cao; Y X Ge; B G Zhang; J P Zhao; X F Cheng
Journal:  J Tongji Med Univ       Date:  1994

6.  Acetylcholine receptor-specific suppressive T-cell factor from a retrovirally transformed T-cell line.

Authors:  F Sinigaglia; C Gotti; R Castagnoli; F Clementi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

7.  Myasthenia gravis: long-term prognostic value of thymus lactate dehydrogenase isoenzyme pattern of hyperplastic thymus and thymoma.

Authors:  I Szathmáry; L Selmeci; E Pósch; A Szobor; J Molnár
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-08       Impact factor: 10.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.